Medical Crossfire®: Multidisciplinary Discussions on the Application of Novel EGFR exon 20 Targeted Regimens for NSCLC Management

Release Date: June 6, 2022

Expiration Date: August 30, 2022

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in non-small cell lung cancer (NSCLC), namely novel EGFR exon 20 targeted regimens. In this educational program, these experts use a case-based format to discuss molecular testing, review the latest clinical data regarding novel therapies, share practical issues related to best practices, and forecast trials and upcoming clinical data.

This educational activity is an archive of the live symposium held on June 5, 2022.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward medical oncologists, surgical oncologists, pathologists, NP/PAs, nurses, and other oncology healthcare professionals.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Assess optimal molecular testing strategies for patients with NSCLC and EGFR exon 20 insertions along the continuum of care
• Describe the role of multidisciplinary team members in the delivery of care for patients with NSCLC and EGFR exon 20 insertions
• Apply safety and efficacy results from clinical trials assessing targeted approaches for the management of patients with advanced NSCLC and EGFR exon 20 insertions
• Summarize approaches to mitigate and manage treatment-related adverse events associated with the use of targeted therapy in patients with NSCLC and EGFR exon 20 insertions

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.